Reviewed by Michael Gill, B. Sc.
25 Eczema Clinical Trials Near Me
Top Hospitals for Eczema Clinical Trials
Image of Dermatology Research Associates in California.
Dermatology Research Associates
Los Angeles
7Active Trials
24All Time Trials for Eczema
2005First Eczema Trial
Image of ForCare Clinical Research in Florida.
ForCare Clinical Research
Tampa
6Active Trials
21All Time Trials for Eczema
2016First Eczema Trial
Top Cities for Eczema Clinical Trials
Image of Miami in Florida.
Miami
74Active Trials
Galderma Investigational Site 8719Top Active Site
Eczema Clinical Trials by Phase of Trial
Phase < 1 Eczema Clinical Trials
1Active Eczema Clinical Trials
1Number of Unique Treatments
1Number of Active Locations
Dupilumab
Eczema Clinical Trials by Age Group
< 18 Eczema Clinical Trials
18Active Eczema Clinical Trials
Lebrikizumab (Cohort 1)ARQ-151 cream 0.15%CrisaboroleTri-lipid skin barrier cream (Epiceram)Upadacitinib (ABT-494)Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil creamDupilumabRuxolitinib Cream
Most Recent Eczema Clinical Trials
Top Treatments for Eczema Clinical Trials
Treatment Name
Active Eczema Clinical Trials
All Time Trials for Eczema
First Recorded Eczema Trial
Dupilumab
7
31
2011
Nemolizumab
5
8
2017
Upadacitinib
5
10
2016
Delgocitinib
3
4
2021
Tralokinumab
2
12
2017
Recently Completed Studies with FDA Approved Treatments for Eczema
Treatment
Year
Sponsor
Tapinarof cream, 1%
2021
Dermavant Sciences, Inc.
LEO 138559
2021
LEO Pharma
KT-474
2021
Kymera Therapeutics, Inc.
ARQ-151 Active
2021
Arcutis Biotherapeutics, Inc.
Lebrikizumab
2020
Eli Lilly and Company
Benralizumab
2020
AstraZeneca
CBP-201
2020
Suzhou Connect Biopharmaceuticals, Ltd.
B244
2020
AOBiome LLC
Lebrikizumab
2019
Eli Lilly and Company

What are Eczema Clinical Trials?

Eczema is a chronic skin condition that presents as itchy, inflamed, dry skin anywhere on the body. Also known as atopic dermatitis, other symptoms include rashes, small bumps, crusting, skin thickening, and hyperpigmentation.

This condition is long-term and can affect all ages. It can persist for years or reoccur in episodes where it flares up the regresses. Generally, these dry patches develop at a young age (5 and under) and continue through adulthood.

People with eczema are more susceptible to other issues, such as asthma, food allergies, and hay fever, as the skin barrier is weak and unable to protect the body from bacteria, allergens, and irritants. Eczema is not contagious and is not caused by improper hygiene.

Why Is Eczema Being Studied Through Clinical Trials?

Eczema affects nearly 31.6 million Americans to some degree, from infants to elders. This accounts for nearly 10% of the population. Researchers still have not identified why this skin condition develops and have yet to find a cure. This is why it is vital to study its causes, treatments, and risk factors.

What Are The Types of Treatments Available For Eczema?

Dermatologists tailor a combination of medicated ointments, creams, and skincare routines based on a patient’s symptoms. Most often, cortisone creams and antihistamines are prescribed to combat the severe itchiness that can lead to superficial cuts and later skin infections.

People with eczema have to make lifestyle adjustments to manage this skin condition, which include:

  • Wearing loose-fitting, cotton fabrics
  • Bathing (or showering) can be no longer than 10 minutes a day
  • Washing with a medicated cleanser
  • Applying a thick moisturizer at least twice a day
  • Using fragrance-free, dye-free detergents
  • Avoiding extreme temperatures and environments

Eczema can severely affect a person's self-esteem and mental health. Many doctors also encourage their patients to seek professional counseling to help them deal with the emotions that arise from managing this skin issue.

What Are Some Recent Breakthrough Clinical Trials for Eczema?

Studies have helped researchers establish many factors that cause and aggravate eczema. This includes an overactive immune system, genetic markers, environmental irritants, and stress.

2016: A study published in the Australasian Journal of Dermatology details a link between eczema and the microorganisms that live in the human body, also known as the human microbiome, specifically in the gut. Evidence shows that what children are fed in their early years can affect the chances of developing eczema.

2019: A study published in the Pediatric Allergy and Immunology Journal found that women fed fermented foods during pregnancy had babies less likely to have eczema. This reinforces the importance of diet in controlling skin conditions.

2020: New medications such as topical immunomodulators (TIMs) have been shown to help people with eczema who haven’t found relief in other therapies.

Who Are Some of the Key Opinion Leaders / Researchers / Institutions Conducting Eczema Clinical Trial Research?

The National Eczema Association (NEA) is a non-government organization that strives to educate and share knowledge on ways people with eczema and their families can manage this skin condition. The NEA works with the Scientific & Medical Advisory Council (SMAC) to guide research and clinical trials.

The American Academy of Dermatology is the chief dermatological association in the country. With over 20,000 physicians worldwide, this organization helps facilitate programs to discover new tests and treatments for skin conditions such as eczema.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 30th, 2021

Last Reviewed: October 31st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.